Literature DB >> 19655082

An autosomal dominant hypophosphatemic rickets phenotype in a Tunisian family caused by a new FGF23 missense mutation.

Moez Gribaa1, Mohamed Younes, Yosra Bouyacoub, Wided Korbaa, Ilhem Ben Charfeddine, Mongi Touzi, Labiba Adala, Ons Mamay, Naceur Bergaoui, Ali Saad.   

Abstract

Autosomal dominant hypophosphatemic rickets (ADHR) is a rare disease, characterized by isolated renal phosphate wasting, hypophosphatemia, and inappropriately normal 1,25-dihydroxyvitamin D(3) (calcitriol) levels. This syndrome involves rickets with bone deformities in childhood and osteomalacia, osteoporosis, articular and para-articular pain, and fatigue in adulthood. It is caused by mutations in a consensus sequence for proteolytic cleavage of the FGF23 protein. Normally, this protein actively regulates phosphate homeostasis. Here we report a Tunisian family in which one parent and three children show clinical and biological features of ADHR. Mutation analysis of the FGF23 gene finds a heterozygous substitution of the C at position 526 by a T (526 C --> T), leading to an amino acid replacement of the FGF23 protein (R176W) at position 176. This causative new mutation is located in the consensus sequence for the proteolytic cleavage domain. These results confirm the importance of this site in FGF23 function and its essential role in ADHR physiopathology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19655082     DOI: 10.1007/s00774-009-0111-5

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  26 in total

1.  Autosomal dominant hypophosphatemic rickets is linked to chromosome 12p13.

Authors:  M J Econs; P T McEnery; F Lennon; M C Speer
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

2.  "Idiopathic" hypercalciuria and hereditary hypophosphatemic rickets. Two phenotypical expressions of a common genetic defect.

Authors:  M Tieder; D Modai; U Shaked; R Samuel; R Arie; A Halabe; J Maor; J Weissgarten; Z Averbukh; N Cohen
Journal:  N Engl J Med       Date:  1987-01-15       Impact factor: 91.245

3.  Osteomalacia as a very late manifestation of primary hyperparathyroidism.

Authors:  F S Kaplan; S R Soffer; M D Fallon; J G Haddad; M Dalinka; E C Raffensperger
Journal:  Clin Orthop Relat Res       Date:  1988-03       Impact factor: 4.176

Review 4.  Phosphate diabetes, tubular phosphate reabsorption and phosphatonins.

Authors:  Michel Laroche; Jean-Frederic Boyer
Journal:  Joint Bone Spine       Date:  2004-12-15       Impact factor: 4.929

Review 5.  Renal phosphate loss in hereditary and acquired disorders of bone mineralization.

Authors:  Bernhard Bielesz; Klaus Klaushofer; Rainer Oberbauer
Journal:  Bone       Date:  2004-12       Impact factor: 4.398

6.  Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.

Authors: 
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

7.  Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder.

Authors:  M J Econs; P T McEnery
Journal:  J Clin Endocrinol Metab       Date:  1997-02       Impact factor: 5.958

8.  FGF23 is processed by proprotein convertases but not by PHEX.

Authors:  Anna Benet-Pagès; Bettina Lorenz-Depiereux; Hans Zischka; Kenneth E White; Michael J Econs; Tim M Strom
Journal:  Bone       Date:  2004-08       Impact factor: 4.398

9.  Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23.

Authors:  Yuji Yamazaki; Taro Tamada; Noriyuki Kasai; Itaru Urakawa; Yukiko Aono; Hisashi Hasegawa; Toshiro Fujita; Ryota Kuroki; Takeyoshi Yamashita; Seiji Fukumoto; Takashi Shimada
Journal:  J Bone Miner Res       Date:  2008-09       Impact factor: 6.741

Review 10.  Osteomalacia associated with adult Fanconi's syndrome: clinical and diagnostic features.

Authors:  B L Clarke; A G Wynne; D M Wilson; L A Fitzpatrick
Journal:  Clin Endocrinol (Oxf)       Date:  1995-10       Impact factor: 3.478

View more
  20 in total

Review 1.  Hereditary disorders of renal phosphate wasting.

Authors:  Amir S Alizadeh Naderi; Robert F Reilly
Journal:  Nat Rev Nephrol       Date:  2010-10-05       Impact factor: 28.314

Review 2.  Miscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and αKlotho).

Authors:  Emily G Farrow; Erik A Imel; Kenneth E White
Journal:  Best Pract Res Clin Rheumatol       Date:  2011-10       Impact factor: 4.098

3.  Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice.

Authors:  Emily G Farrow; Xijie Yu; Lelia J Summers; Siobhan I Davis; James C Fleet; Matthew R Allen; Alexander G Robling; Keith R Stayrook; Victoria Jideonwo; Martin J Magers; Holly J Garringer; Ruben Vidal; Rebecca J Chan; Charles B Goodwin; Siu L Hui; Munro Peacock; Kenneth E White
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

Review 4.  The rachitic tooth.

Authors:  Brian L Foster; Francisco H Nociti; Martha J Somerman
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

5.  Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans.

Authors:  Erik A Imel; Munro Peacock; Amie K Gray; Leah R Padgett; Siu L Hui; Michael J Econs
Journal:  J Clin Endocrinol Metab       Date:  2011-08-31       Impact factor: 5.958

6.  Novel vitamin D 1α-hydroxylase gene mutations in a Chinese vitamin-D-dependent rickets type I patient.

Authors:  Lihua Cao; Fang Liu; Yu Wang; Jian Ma; Shusen Wang; Libo Wang; Yang Zhang; Chen Chen; Yang Luo; Hongwei Ma
Journal:  J Genet       Date:  2011-08       Impact factor: 1.166

Review 7.  Can features of phosphate toxicity appear in normophosphatemia?

Authors:  Satoko Osuka; Mohammed S Razzaque
Journal:  J Bone Miner Metab       Date:  2012-01-05       Impact factor: 2.626

Review 8.  Fibroblast growth factor signalling in osteoarthritis and cartilage repair.

Authors:  Yangli Xie; Allen Zinkle; Lin Chen; Moosa Mohammadi
Journal:  Nat Rev Rheumatol       Date:  2020-08-17       Impact factor: 20.543

Review 9.  Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease.

Authors:  Myles Wolf; Kenneth E White
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-07       Impact factor: 2.894

Review 10.  FGF23 and syndromes of abnormal renal phosphate handling.

Authors:  Clemens Bergwitz; Harald Jüppner
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.